|
| Research on the traditional Chinese medicine characteristic therapy of chronic obstructive pulmonary disease under active health strategy |
| Hits 840 Download times 489 Received:October 28, 2021 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2022.01.08 |
| Key Words
active health strategy;COPD;lung and kidney qi deficiency syndrome;traditional Chinese medicine characteristic therapy;clinical study |
| Author Name | Affiliation | E-mail | | ZHANG Xingxing | Respiratory Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China
Institute of Respiratory Disease, Anhui Academy of Chinese Medicine, Hefei 230031, China | | | GAO Yating | Institute of Respiratory Disease, Anhui Academy of Chinese Medicine, Hefei 230031, China
Anhui University of Chinese Medicine, Hefei 230032, China | | | WANG Xiaole | Institute of Respiratory Disease, Anhui Academy of Chinese Medicine, Hefei 230031, China
Anhui University of Chinese Medicine, Hefei 230032, China | | | YANG Qinjun | Institute of Respiratory Disease, Anhui Academy of Chinese Medicine, Hefei 230031, China
Anhui University of Chinese Medicine, Hefei 230032, China | | | YANG Cheng | Respiratory Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China
Institute of Respiratory Disease, Anhui Academy of Chinese Medicine, Hefei 230031, China | | | TONG Jiabing | Respiratory Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China
Institute of Respiratory Disease, Anhui Academy of Chinese Medicine, Hefei 230031, China | | | LI Zegeng | Institute of Respiratory Disease, Anhui Academy of Chinese Medicine, Hefei 230031, China
Anhui University of Chinese Medicine, Hefei 230032, China | muyi802@126.com |
|
| Abstract
|
| [Objective] To evaluate the therapeutic effect of traditional Chinese medicine(TCM) characteristic therapy on chronic obstructive pulmonary disease (COPD) in the stable period of lung and kidney qi deficiency. [Methods] The inclusion criteria were met in 80 patients with COPD at stable stage of pulmonary lung and kidney qi deficiency. The patients were randomly divided into conventional Western medicine treatment group (40 cases) and traditional Chinese medicine characteristic treatment group (40 cases). The patients in the conventional treatment group were given salmeteroticasone inhalant 50 μg/250 μg (Supratide). On the basis of the former,the patients in the TCM characteristic treatment group were given TCM characteristic pulmonary rehabilitation therapy,including TCM oral administration + classical acupoint application + TCM ion introduction. Each course of treatment is 2 months,divided into 3 treatment stages;the total course of treatment is 6 months. At the 6th month of follow-up,pulmonary function,number of acute exacerbations,changes in CAT score,western medicine symptom score and traditional Chinese medicine syndrome score of the two groups were evaluated before and after treatment. [Results] The number of acute exacerbations,CAT score and western medicine symptom score after treatment were decreased in both groups (P<0.05 or P<0.01). FEV1 in the TCM characteristic treatment group was slightly improved compared with the conventional treatment group (P<0.05),and could reduce the TCM syndrome score of the patients. [Conclusion] The characteristic treatment of TCM can delay the decline of pulmonary function in patients with COPD to some extent,reduce the number of patients with acute aggravation,and improve the disease status of patients. |
|
|
|
|
|
|
|
